학술논문
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Document Type
Article
Author
Langdahl, Bente L; Libanati, Cesar; Crittenden, Daria B; Bolognese, Michael A; Brown, Jacques P; Daizadeh, Nadia S; Dokoupilova, Eva; Engelke, Klaus; Finkelstein, Joel S; Genant, Harry K; Goemaere, Stefan; Hyldstrup, Lars; Jodar-Gimeno, Esteban; Keaveny, Tony M; Kendler, David; Lakatos, Peter; Maddox, Judy; Malouf, Jorge; Massari, Fabio E; Molina, Jose Fernando; Ulla, Maria Rosa; Grauer, Andreas
Source
In The Lancet 30 September-6 October 2017 390(10102):1585-1594
Subject
Language
ISSN
0140-6736